By Topic

The use of MiniMed CGMS in real-time glucose monitoring

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$33 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

4 Author(s)

A study was conducted to examine the use of the MiniMed(R) Continuous Glucose Monitoring System (CGMS) to measure blood sugar level (BSL) in real-time. Eight patients participated in the study after informed consent was obtained. When more than a 3 mmol/L deviation occurred between CGMS reading and BSL as determined by conventional blood glucose meter using blood sample drawn from an arterial line, CGMS was re-calibrated, and "regression calibration" was applied to better estimate the real-time BSL. The mean difference between the CGMS and Meter BSL readings was found to be -0.2 ±5.3 mmol/L (Mean±1.96×Standard Deviation). Clarke's Error grid analysis showed that 64.6% of the CGMS BSL readings were clinically accurate (i.e. <20% deviation from Meter BSL) while 30.9% were clinically acceptable. A calibration technique suitable for use in estimating BSL in real-time is needed to make CGMS useful in clinical situations.

Published in:

Intelligent Information Systems Conference, The Seventh Australian and New Zealand 2001

Date of Conference:

18-21 Nov. 2001